Profile of:

Vinod Chandran


Full name: Vinod Chandran

Current country: Canada

Membership level: Full

Type of membership: Member

Number of publications: 18

Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial (2023)
https://pubmed.ncbi.nlm.nih.gov/37945284/

Identifying Serum Metabolomic Markers Associated with Skin Disease Activity in Patients with Psoriatic Arthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37894979/

Risankizumab for the treatment of active psoriatic arthritis in adults (2023)
https://pubmed.ncbi.nlm.nih.gov/37772959/

A Solid-Phase Microextraction-Liquid Chromatography-Mass Spectrometry Method for Analyzing Serum Lipids in Psoriatic Disease (2023)
https://pubmed.ncbi.nlm.nih.gov/37623906/

Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37326480/

Effectiveness of Disease-Modifying Antirheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35649547/

Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35471956/

Defining imaging sub-phenotypes of psoriatic arthritis: integrative analysis of imaging data and gene expression in a PsA patient cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35157043/

Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. (2021)
https://pubmed.ncbi.nlm.nih.gov/34137950/

Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33763056/

Insights into the pathogenesis of psoriatic arthritis from genetic studies (2021)
https://pubmed.ncbi.nlm.nih.gov/33712923/

Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients with Psoriatic Arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33662181/

Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/33774593/

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) (2021)
https://pubmed.ncbi.nlm.nih.gov/34987619/

Autoantibodies in Psoriatic Disease (2021)
https://pubmed.ncbi.nlm.nih.gov/34996072/

Oligoarticular vs Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics (2021)
https://pubmed.ncbi.nlm.nih.gov/34334360/

Metabolomics Studies in Psoriatic Disease: A Review (2021)
https://pubmed.ncbi.nlm.nih.gov/34200760/

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study (2021)
https://pubmed.ncbi.nlm.nih.gov/33682378/